Henan Cancer Hospital

This study is testing if a drug called toripalimab can help prevent esophageal cancer from returning after surgery. It will involve 435 patients who have already had surgery to remove their cancer. Some patients will receive the drug for up to a year after surgery, while others w…

This study is testing whether adding an immunotherapy drug (toripalimab) to different chemotherapy combinations works better to shrink triple-negative breast cancer tumors before surgery. Researchers want to see which treatment plan is more effective and safer for patients. The g…

This study is testing whether combining radiation therapy with two drugs (tislelizumab and anlotinib) can help control advanced liver cancer that has spread into a major vein. It aims to shrink tumors, stop their growth, and potentially make surgery an option for some patients. T…

This study aims to compare how well three different treatment combinations work for people newly diagnosed with marginal zone B-cell lymphoma, a type of blood cancer. Researchers will follow 131 patients receiving either BR, R2, or OR2 treatment regimens to see which approach bes…

This study will observe how well the drug glofitamab works for patients with aggressive lymphoma that didn't respond to initial treatment or returned quickly. Doctors will follow about 20 patients receiving this treatment as part of their regular care to see how they respond and …

This study compares two newer targeted drugs for HER2-positive breast cancer when given before surgery. It aims to see which drug helps more patients achieve a complete disappearance of cancer in the breast and lymph nodes after treatment. The trial will also track side effects a…

This study looks back at medical records to see if continuing the drug anlotinib helps control advanced lung cancer, even after the cancer has started growing again. It will include about 350 people with specific types of lung cancer who kept taking anlotinib or switched to other…

This study is testing a combination injection to prevent nausea and vomiting in lung cancer patients who are receiving chemotherapy and radiation at the same time. It will compare two different anti-nausea drug combinations to see which one works better. The goal is to improve co…

This study aims to develop an artificial intelligence (AI) tool to help doctors choose the best treatment for people with esophageal cancer. It will analyze thousands of patient scans and tissue samples to learn which treatments lead to the best outcomes. The goal is to create a …